Salt-restricted diet
Salt-restricted diet has been studied in 1 paper since 2025: 1 observational study in people. The newest paper, Jul 15, 2025: “Impacts of salt restriction on nutritional status, sarcopenia, and mortality of cirrhotic patients with ascites”.
1 paper studies it3 findingsUpdated
See all 1 papers on salt-restricted diet
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“The SRD group showed better ascites control, with fewer paracentesis sessions per month (1.57 ± 0.65 vs. 4.07 ± 1.43, p < 0.001).”
None of its findings points the other way.
- 1 lab in 1 country
- Humans1
What did studies of salt-restricted diet find?
1Studies of salt-restricted diet measured one outcome, ascites.
Ascites
downin humans1
1 study
Ascites
downin humans1
Salt-restricted diet is linked with lower ascites in cirrhotic patients with decompensated liver disease and grade III ascites (1.57 ± 0.65 vs. 4.07 ± 1.43 sessions/month, p < 0.001).
“The SRD group showed better ascites control, with fewer paracentesis sessions per month (1.57 ± 0.65 vs. 4.07 ± 1.43, p < 0.001).”
Humansin cirrhotic patients with decompensated liver disease and grade III ascitessix monthsn = 102
BMC gastroenterology
What is salt-restricted diet linked with?
2Studies link salt-restricted diet with 2 measures: mortality and sarcopenia.
Mortality
upin humans1OR 1.65
1 study
Mortality
upin humans1OR 1.65
Salt-restricted diet is linked with a higher risk of mortality in cirrhotic patients with decompensated liver disease and grade III ascites (67.4% vs. 35.7%, OR = 1.65, p < 0.001).
“Multivariate analysis identified sarcopenia (OR = 2.684, p = 0.006) and SRD (OR = 1.65, p < 0.001) as independent predictors of mortality.”
Humansin cirrhotic patients with decompensated liver disease and grade III ascitessix monthsn = 102
BMC gastroenterology
Sarcopenia
upin humans1
1 study
Sarcopenia
upin humans1
Salt-restricted diet is linked with a higher risk of sarcopenia in cirrhotic patients with decompensated liver disease and grade III ascites (p < 0.001).
“Sarcopenia was more prevalent in the SRD group (p < 0.001), with lower SMI (4.88 ± 7.13 vs. 16.7 ± 544.8, p < 0.001) and TR PMM (19.03 ± 3.68 vs. 71.92 ± 191.9, p < 0.001).”
Humansin cirrhotic patients with decompensated liver disease and grade III ascitessix monthsn = 102
BMC gastroenterology